Literature DB >> 22213427

β-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis.

Mei-Xia Zhao1, Liang-Nian Ji, Zong-Wan Mao.   

Abstract

The use of active components from important medical herbs has proved effective in treating various cancers. Glycyrrhizic acid (GA) is one of the many interesting triterpenoic acids with anticancerogenic potential, and is known to trigger apoptosis in hepatocarcinoma cells. In this study we combined quantum dots (QDs) with GA in the presence of β-cyclodextrin (β-CD), and prepared β-CD/GA-functionalised QDs, which led to improved antitumor activity and induced apoptosis in hepatocarcinoma cells. These compounds showed a better selectivity for hepatic cells compared to HeLa and ECV-304 cells. Hoechst and annexin V-FITC staining and mitochondrial membrane potential (MMP) experiments proved an apoptotic effect of these compounds on HepG2 cells. At the same time, transmission electron microscopy (TEM) showed obvious features of apoptosis, for example, irregularities of nuclear shapes, mitochondria swelling, clumping and peripheral chromatin condensation, zeiosis or blebbing of the plasma membrane and formation of apoptotic bodies. It is notable that β-CD/GA-functionalised QDs showed effective cell growth inhibition by triggering G0/G1 phase arrest and inducing apoptosis through an reactive oxygen species mediated mitochondrial dysfunction pathway. β-CD/GA-functionalised QDs primarily induced apoptotic response in a time- and dose-dependent manner, but little apoptosis appeared with L-Cys-β-CD-functionalised QDs or GA alone. These studies suggest that β-CD/GA-functionalised QDs have therapeutic potential against cancer.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213427     DOI: 10.1002/chem.201102795

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Meta-analysis of cellular toxicity for cadmium-containing quantum dots.

Authors:  Eunkeu Oh; Rong Liu; Andre Nel; Kelly Boeneman Gemill; Muhammad Bilal; Yoram Cohen; Igor L Medintz
Journal:  Nat Nanotechnol       Date:  2016-02-29       Impact factor: 39.213

Review 2.  Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.

Authors:  Jing-Jun Yan; Jia-Zhi Liao; Ju-Sheng Lin; Xing-Xing He
Journal:  Tumour Biol       Date:  2014-11-26

3.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

4.  Application of functional quantum dot nanoparticles as fluorescence probes in cell labeling and tumor diagnostic imaging.

Authors:  Mei-Xia Zhao; Er-Zao Zeng
Journal:  Nanoscale Res Lett       Date:  2015-04-10       Impact factor: 4.703

5.  Preparation, Characterization, and In Vitro Evaluation of Inclusion Complexes Formed between S-Allylcysteine and Cyclodextrins.

Authors:  Rino Tachikawa; Hiroki Saito; Hajime Moteki; Mitsutoshi Kimura; Hiroaki Kitagishi; Florencio Arce; Gerard Lee See; Takashi Tanikawa; Yutaka Inoue
Journal:  ACS Omega       Date:  2022-08-24

6.  A Lysosome-Targetable Fluorescence Probe Based on L-Cysteine-Polyamine-Morpholine-Modified Quantum Dots for Imaging in Living Cells.

Authors:  Zhi-Qiang Zhang; Wen-Jing Yao; Lu-Lu Qiao; Xiaojing Yang; Jiahua Shi; Mei-Xia Zhao
Journal:  Int J Nanomedicine       Date:  2020-03-09

Review 7.  The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents.

Authors:  Alexandra Prodea; Alexandra Mioc; Christian Banciu; Cristina Trandafirescu; Andreea Milan; Roxana Racoviceanu; Roxana Ghiulai; Marius Mioc; Codruta Soica
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.